Skip to main content
Biotricity, Inc. (BTCY)
NASDAQ: BTCY · IEX Real-Time Price · USD
1.302
-0.068 (-4.96%)
At close: May 2, 2024, 3:59 PM
1.292
-0.010 (-0.77%)
After-hours: May 2, 2024, 7:48 PM EDT

Biotricity Revenue

Biotricity had revenue of $11.63M in the twelve months ending December 31, 2023, with 28.55% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $2.97M with 20.89% year-over-year growth. In the fiscal year ending March 31, 2023, Biotricity had annual revenue of $9.64M with 26.00% growth.

Revenue (ttm)
$11.63M
Revenue Growth
+28.55%
P/S Ratio
1.04
Revenue / Employee
$211,409
Employees
55
Market Cap
12.06M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20239.64M1.99M26.00%
Mar 31, 20227.65M4.27M126.02%
Mar 31, 20213.38M1.97M138.75%
Mar 31, 20201.42M1.02M256.03%
Mar 31, 2019398.20K--
Mar 31, 20180--
Mar 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CareMax 751.10M
Cosmos Health 49.59M
Zhongchao 17.23M
Elevai Labs 1.71M
Organovo Holdings 242.00K
Nexalin Technology 110.75K
Revenue Rankings

BTCY News

More News